JP2004506632A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506632A5
JP2004506632A5 JP2002519452A JP2002519452A JP2004506632A5 JP 2004506632 A5 JP2004506632 A5 JP 2004506632A5 JP 2002519452 A JP2002519452 A JP 2002519452A JP 2002519452 A JP2002519452 A JP 2002519452A JP 2004506632 A5 JP2004506632 A5 JP 2004506632A5
Authority
JP
Japan
Prior art keywords
methyl
tetrazol
phenyl
thiazol
cyclopentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002519452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506632A (ja
JP3961948B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/009207 external-priority patent/WO2002014312A1/en
Publication of JP2004506632A publication Critical patent/JP2004506632A/ja
Publication of JP2004506632A5 publication Critical patent/JP2004506632A5/ja
Application granted granted Critical
Publication of JP3961948B2 publication Critical patent/JP3961948B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002519452A 2000-08-15 2001-08-09 テトラゾリル−フェニルアセトアミドであるグルコキナーゼ活性化物質 Expired - Fee Related JP3961948B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22549400P 2000-08-15 2000-08-15
PCT/EP2001/009207 WO2002014312A1 (en) 2000-08-15 2001-08-09 Tetrazolyl-phenyl acetamide glucokinase activators

Publications (3)

Publication Number Publication Date
JP2004506632A JP2004506632A (ja) 2004-03-04
JP2004506632A5 true JP2004506632A5 (OSRAM) 2005-03-17
JP3961948B2 JP3961948B2 (ja) 2007-08-22

Family

ID=22845106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002519452A Expired - Fee Related JP3961948B2 (ja) 2000-08-15 2001-08-09 テトラゾリル−フェニルアセトアミドであるグルコキナーゼ活性化物質

Country Status (20)

Country Link
US (3) US6369232B1 (OSRAM)
EP (1) EP1311504B1 (OSRAM)
JP (1) JP3961948B2 (OSRAM)
KR (1) KR100518061B1 (OSRAM)
CN (1) CN1209362C (OSRAM)
AR (1) AR031718A1 (OSRAM)
AT (1) ATE297921T1 (OSRAM)
AU (2) AU8399801A (OSRAM)
BR (1) BR0113312A (OSRAM)
CA (1) CA2419416C (OSRAM)
DE (1) DE60111540T2 (OSRAM)
DK (1) DK1311504T3 (OSRAM)
ES (1) ES2243541T3 (OSRAM)
MX (1) MXPA03001275A (OSRAM)
PA (1) PA8525201A1 (OSRAM)
PE (1) PE20020386A1 (OSRAM)
PT (1) PT1311504E (OSRAM)
UY (1) UY26885A1 (OSRAM)
WO (1) WO2002014312A1 (OSRAM)
ZA (1) ZA200300904B (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
HK1079788A1 (zh) * 2002-10-03 2006-04-13 Novartis Ag 适用於治疗2型糖尿病的作为葡萄糖激酶活化剂的取代的(噻唑-2-基)-酰胺或磺胺
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
MY141521A (en) 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
AU2003294376A1 (en) * 2003-01-06 2004-08-10 Eli Lilly And Company Heteroaryl compounds
EP1594863A1 (en) * 2003-02-11 2005-11-16 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
WO2005095417A1 (en) 2004-04-02 2005-10-13 Novartis Ag Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
EP1735322B1 (en) 2004-04-02 2011-09-14 Novartis AG Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful for the treatment of type 2 diabetes
KR101346902B1 (ko) 2005-07-09 2014-01-02 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
WO2007007886A1 (en) 2005-07-11 2007-01-18 Mitsubishi Tanabe Pharma Corporation An oxime derivative and preparations thereof
CA2621227A1 (en) 2005-08-31 2007-03-08 Astellas Pharma Inc. Thiazole derivative
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
BRPI0617207A2 (pt) 2005-09-29 2011-07-19 Sanofi Aventis derivados de fenil-1,2,4-oxadiazolona, processos para sua preparação e seu uso como produtos farmacêuticos
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
JP2009514835A (ja) * 2005-11-03 2009-04-09 プロシディオン・リミテッド トリシクロ置換型アミド
WO2007061923A2 (en) * 2005-11-18 2007-05-31 Takeda San Diego, Inc. Glucokinase activators
US7994339B2 (en) * 2005-12-15 2011-08-09 Nihon Nohyaku Co., Ltd. Phthalamide derivative, agricultural or horticultural pesticide, and use of the pesticide
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
JP5386350B2 (ja) 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
US7910747B2 (en) * 2006-07-06 2011-03-22 Bristol-Myers Squibb Company Phosphonate and phosphinate pyrazolylamide glucokinase activators
US7902248B2 (en) 2006-12-14 2011-03-08 Hoffmann-La Roche Inc. Oxime glucokinase activators
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
TW200831081A (en) 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
WO2008084872A1 (ja) 2007-01-10 2008-07-17 Mitsubishi Tanabe Pharma Corporation ヒドラゾン誘導体
BRPI0808267A2 (pt) 2007-03-07 2014-07-22 Kyorin Phamaceutical Co., Ltd "composto representado pela formula geral (1) ou um sal farmeceuticamente aceitável do mesmo; método para o tratamento ou prevenção de diabetes ; uso do composto; composição farmacêutica e composto representado pela formula geral (3)".
US8173645B2 (en) * 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
ES2446932T3 (es) * 2007-10-08 2014-03-10 Advinus Therapeutics Private Limited Derivados de acetamida como activadores de glucoquinasa, su procedimiento y aplicaciones en medicina
AR070107A1 (es) * 2008-01-15 2010-03-17 Lilly Co Eli R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia
KR20100113518A (ko) * 2008-01-18 2010-10-21 아스텔라스세이야쿠 가부시키가이샤 페닐아세트아미드 유도체
PL2275414T3 (pl) 2008-04-28 2016-01-29 Kyorin Seiyaku Kk Pochodne cyklopentyloakryloamidu
AU2011235212B2 (en) 2010-03-31 2014-07-31 The Scripps Research Institute Reprogramming cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
GB8909574D0 (en) 1989-04-26 1989-06-14 Ici Plc Chemical process
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
US5461049A (en) * 1994-05-27 1995-10-24 Warner-Lambert Company Amide tetrazole ACAT inhibitors
BR9807096A (pt) * 1997-01-28 2000-04-18 Merck & Co Inc Composto, processos para o tratamento do diabetes, da obesidade em um mamìfero, para reduzir nìveis de triglicerìdeos e nìveis de colesterol ou elevar nìveis de lipoproteìnas de alta densidade, para diminuir a motilidade do intestino, para reduzir inflamação neurogênica das vias aéreas e a depressão e para tratar distúrbios gastrintestinais, e, composições para o tratamento dos distúrbios acima e farmacêutica
SI1169312T1 (en) * 1999-03-29 2005-02-28 F. Hoffmann-La Roche Ag Glucokinase activators

Similar Documents

Publication Publication Date Title
JP2004506632A5 (OSRAM)
JP2004521095A5 (OSRAM)
JP2004504301A5 (OSRAM)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2016503786A5 (OSRAM)
JP2010538076A5 (OSRAM)
JP2007530459A5 (OSRAM)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
CA2430579A1 (en) Isoindolin-1-one glucokinase activators
RU2003120512A (ru) Активаторы изоиндолин-1-он-глюкокиназы
JP2015517981A5 (OSRAM)
JP2004517087A5 (OSRAM)
JP2005508923A5 (OSRAM)
JP2004517080A5 (OSRAM)
JP2004532209A5 (OSRAM)
RU2010120676A (ru) Азолкарбоксамидное соединение или его соль
RU2420522C2 (ru) Новый класс ингибиторов гистондеацетилаз
JP2005517006A5 (OSRAM)
JP2013512899A5 (OSRAM)
JP2010520893A5 (OSRAM)
JP2012530705A5 (OSRAM)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
JP2005507918A5 (OSRAM)
CA2437409A1 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
JP2013503167A5 (OSRAM)